Archived Newsletters
-
06.24.25 -- A Psychedelic Path To CDMO Selection?
6/24/2025
06/24/25 Outsourced Pharma Newsletter
-
06.23.25 -- STREAM Edition: Drug Development Outsourcing: The Devil Is In The Details
6/23/2025
06/23/25 Outsourced Pharma Newsletter
-
06.23.25 -- Is An Outsourced BD Model Gaining Traction At CDMOs?
6/23/2025
06/23/25 Outsourced Pharma Newsletter
-
06.20.25 -- Late-Stage Formulation Is A Different Ballgame. Insights From An Allstar
6/20/2025
06/20/25 Outsourced Pharma Newsletter
-
06.19.25 -- A Psychedelic Path To CDMO Selection?
6/19/2025
06/19/25 Outsourced Pharma Newsletter
-
06.18.25 -- Your helping hand in filtration for high concentration drugs.
6/18/2025
06/18/25 Outsourced Pharma Newsletter
-
06.18.25 -- How A Biotech Navigates The CDMO Frenzy For GLP-1 Services
6/18/2025
06/18/25 Outsourced Pharma Newsletter
-
06.17.25 -- Eliminate Scale-Up Surprises: CMC Insights For Every Phase
6/17/2025
06/17/25 Outsourced Pharma Newsletter
-
06.17.25 -- What Biotechs Learn From Takeda's Internal Manufacturing Competition
6/17/2025
06/17/25 Outsourced Pharma Newsletter
-
06.16.25 -- STREAM Edition: You Need 'Brutal Honesty' When Outsourcing
6/16/2025
06/16/25 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more